Bliss Gvs Pharma Ltd. - Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter & Half Year Ended September 30, 2018.

BLISS GVS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2018 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter & half year ended September 30, 2018.

Further, pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation, 2015 read with the provision of the code of fair disclosure of the Company, the trading window of the Company will be closed from Thursday, October 25, 2018 to Monday, November 05, 2018 (both days inclusive).

Kindly acknowledge and take on record the same.

Pdf Link: Bliss Gvs Pharma Ltd. - Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter & Half Year Ended September 30, 2018.

Source : BSE - www.bseindia.com

Published on October 24, 2018

Related

This article is closed for comments.
Please Email the Editor